Whole-exome sequencing to identify HOMEZ mutation as a prognostic marker in esophageal squamous cell carcinoma treated with concurrent chemoradiotherapy. This is an ASCO Meeting Abstract from the 2017 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results